Guerbet
19.66
08-四月-25 11:15:22
15 分钟延时
股票
+1.15
+6.21%
今日范围
18.92 - 20.10
ISIN
FR0000032526
来源
Cboe
-
22 3月 2023 12:45:58 条件 Nasdaq GlobeNewswire
-
09 2月 2023 11:46:34 条件 Nasdaq GlobeNewswire
-
Guerbet: 2023 Strategic Priorities
16 1月 2023 12:40:42 条件 Nasdaq GlobeNewswire
-
11 1月 2023 13:46:47 条件 Nasdaq GlobeNewswire
-
Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects
03 11月 2022 13:04:18 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at September 30, 2022
20 10月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)
21 9月 2022 13:00:00 条件 Nasdaq GlobeNewswire
-
Guerbet: 2022 half-year results
21 9月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at June 30, 2022
21 7月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet receives EMA acceptance of EluciremTM as the Brand Name for Gadopiclenol
13 6月 2022 02:30:00 条件 Nasdaq GlobeNewswire
-
21 4月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
06 4月 2022 02:30:00 条件 Nasdaq GlobeNewswire
-
29 3月 2022 12:05:55 条件 Nasdaq GlobeNewswire
-
23 3月 2022 12:45:00 条件 Nasdaq GlobeNewswire
-
07 3月 2022 12:00:48 条件 Nasdaq GlobeNewswire
-
10 2月 2022 11:54:31 条件 Nasdaq GlobeNewswire
-
04 1月 2022 12:02:01 条件 Nasdaq GlobeNewswire
-
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol
14 12月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at September 30, 2021
21 10月 2021 11:46:04 条件 Nasdaq GlobeNewswire